Skip to main content
Top
Published in: Infection 6/2016

01-12-2016 | Original Paper

Key priorities in the prevention and control of healthcare-associated infection: a survey of European and other international infection prevention experts

Authors: Markus Dettenkofer, Hilary Humphreys, Henri Saenz, Jean Carlet, Håkan Hanberger, Christian Ruef, Andreas Widmer, Martin Wolkewitz, Barry Cookson

Published in: Infection | Issue 6/2016

Login to get access

Abstract

Purpose

Prevention and control of healthcare-associated infection (HCAI) are important within and beyond Europe. However, it is unclear which areas are considered important by HCAI prevention and control professionals. This study assesses the priorities in the prevention and control of HCAI as judged by experts in the field.

Methods

A survey was conducted by the European Society of Clinical Microbiology and Infectious Diseases focussing on seven topics using SurveyMonkey®. Through a newsletter distributed by email, about 5000 individuals were targeted throughout the world in February and March 2013. Participants were asked to rate the importance of particular topics from one (low importance) to ten (extraordinary importance), and there was no restriction on giving equal importance to more than one topic.

Results

A total of 589 experts from 86 countries participated including 462 from Europe (response rate: 11.8 %). Physicians accounted for 60 % of participants, and 57 % had ten or more years’ experience in this area. Microbial epidemiology/resistance achieved the highest priority scoring with 8.9, followed by surveillance 8.2, and decolonisation/disinfection/antiseptics with 7.9. Under epidemiology/resistance, highly resistant Gram-negative bacilli scored highest (9.0–9.2). The provision of computerised healthcare information systems for the early detection of outbreaks was accorded the top priority under surveillance. The prevention of surgical site and central line infections ranked highest under the category of specific HCAI and HCAI in certain settings. Differences between regions are described.

Conclusion

These findings reflect the concerns of experts in HCAI prevention and control. The results from this survey should inform national and international agencies on future action and research priorities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228–41.CrossRefPubMed Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228–41.CrossRefPubMed
2.
go back to reference World Health Organisation (WHO). Report on the burden of endemic health care-associated infection worldwide. Geneva: WHO; 2011. World Health Organisation (WHO). Report on the burden of endemic health care-associated infection worldwide. Geneva: WHO; 2011.
3.
go back to reference Martin M, Zingg W, Hansen S, et al. PROHIBIT study group. Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders? J Hosp Infect. 2013;83:94–8.CrossRefPubMed Martin M, Zingg W, Hansen S, et al. PROHIBIT study group. Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders? J Hosp Infect. 2013;83:94–8.CrossRefPubMed
4.
go back to reference Surveillance Report. Point prevalence survey of healthcare-associated infections and antimicrobial use in European hospitals 2011-2012. Stockholm: European Centre for Disease Prevention and Control; 2013. Surveillance Report. Point prevalence survey of healthcare-associated infections and antimicrobial use in European hospitals 2011-2012. Stockholm: European Centre for Disease Prevention and Control; 2013.
5.
go back to reference Theuretzbacher U. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. Int J Antimicrob Agent. 2012;39:295–9.CrossRef Theuretzbacher U. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. Int J Antimicrob Agent. 2012;39:295–9.CrossRef
6.
go back to reference Dettenkofer M, Ammon A, Astagneau P, et al. Infection control–a European research perspective for the next decade. J Hosp Infect. 2011;77:7–10.CrossRefPubMed Dettenkofer M, Ammon A, Astagneau P, et al. Infection control–a European research perspective for the next decade. J Hosp Infect. 2011;77:7–10.CrossRefPubMed
7.
go back to reference Struelens MJ, Monnet DL, Magiorakos AP, O’Connor S, Giesecken J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. EuroSurveillance. 2010;15:19716.PubMed Struelens MJ, Monnet DL, Magiorakos AP, O’Connor S, Giesecken J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. EuroSurveillance. 2010;15:19716.PubMed
8.
go back to reference Khan AS, Dancer SJ, Humphreys H. Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals. J Hosp Infect. 2012;82:85–93.CrossRefPubMed Khan AS, Dancer SJ, Humphreys H. Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals. J Hosp Infect. 2012;82:85–93.CrossRefPubMed
10.
go back to reference Magiorakos AP, Leens E, Drouvot V, et al. Pathways to clean hands: highlights of successful hand hygiene implementation strategies in Europe. EuroSurveillance. 2010;15:19560.PubMed Magiorakos AP, Leens E, Drouvot V, et al. Pathways to clean hands: highlights of successful hand hygiene implementation strategies in Europe. EuroSurveillance. 2010;15:19560.PubMed
12.
go back to reference Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. New Engl J Med. 2013;368:2255–65.CrossRefPubMed Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. New Engl J Med. 2013;368:2255–65.CrossRefPubMed
13.
go back to reference Derde LP, Cooper BS, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14:31–9.CrossRefPubMedPubMedCentral Derde LP, Cooper BS, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14:31–9.CrossRefPubMedPubMedCentral
Metadata
Title
Key priorities in the prevention and control of healthcare-associated infection: a survey of European and other international infection prevention experts
Authors
Markus Dettenkofer
Hilary Humphreys
Henri Saenz
Jean Carlet
Håkan Hanberger
Christian Ruef
Andreas Widmer
Martin Wolkewitz
Barry Cookson
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0904-0

Other articles of this Issue 6/2016

Infection 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.